PMC6992468

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Obese childhood ALL survivors (BMI >=30 kg/m2) had over seven-fold higher odds of T2DM compared to non-obese survivors, after adjusting for age, sex, race, education, physical activity, DIDM, and trea

Effect: decline; OR 7.40; CI: 95% CI 2.61-20.97

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61

Among childhood ALL survivors, those who developed drug-induced diabetes during treatment had nearly five-fold higher odds of type 2 diabetes in adulthood compared to those who did not develop DIDM, a

Effect: decline; OR 4.67; CI: 95% CI 2.53-8.61